tiprankstipranks
Opus Genetics (IRD)
NASDAQ:IRD
US Market
IRD
Opus Genetics
RESEARCH TOOLSreports
Want to see IRD full AI Analyst Report?

Opus Genetics (IRD) Financial Statements

1,281 Followers

Opus Genetics Financial Overview

Opus Genetics's market cap is currently $382.72M. The company's EPS TTM is $-0.8; its P/E ratio is -18.92; Opus Genetics is scheduled to report earnings on May 8, 2026, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 14.20M$ 10.99M$ 19.05M$ 39.85M$ 589.00K
Gross Profit$ 14.14M$ 10.99M$ 19.05M$ 39.85M$ 589.00K
Operating Income$ -38.60M$ -62.07M$ -10.56M$ 18.23M$ -22.70M
EBITDA$ -38.60M$ -57.52M$ -9.97M$ 18.22M$ -56.69M
Net Income$ -49.59M$ -57.53M$ -9.99M$ 17.89M$ -56.69M
Balance Sheet
Cash & Short-Term Investments$ 45.09M$ 30.32M$ 50.52M$ 42.68M$ 24.75M
Total Assets$ 50.24M$ 36.86M$ 53.95M$ 48.99M$ 26.08M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 538.00K
Net Debt$ -45.09M$ -30.32M$ -50.50M$ -42.63M$ -24.00M
Total Liabilities$ 34.90M$ 30.14M$ 4.04M$ 2.75M$ 3.85M
Stockholders' Equity$ 15.35M$ 6.72M$ 49.91M$ 46.24M$ 22.22M
Cash Flow
Free Cash Flow$ -35.25M$ -25.58M$ -1.11M$ 14.31M$ -19.37M
Operating Cash Flow$ -35.25M$ -25.58M$ -1.11M$ 14.31M$ -19.37M
Investing Cash Flow$ 0.00$ 1.21M$ 0.00$ 0.00$ -100.00K
Financing Cash Flow$ 50.02M$ 4.19M$ 8.98M$ 3.79M$ 27.61M
Currency in USD

Opus Genetics Earnings and Revenue History

Income Statement >

Opus Genetics Debt to Assets

Balance Sheet >

Opus Genetics Cash Flow

Cash Flow >

Opus Genetics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >